Cited by 72Congenital Heart Disease StudiesCongenital heart defects researchCardiovascular Conditions and Treatments

Long-term outcomes of transatrial-transpulmonary repair of tetralogy of Fallot.

Open access
Luijten, Linda W.G., van den Bosch, Eva, Duppen, Nienke, Tanke, Ronald, Roos-Hesselink, J., Nijveld, Aagje, van Dijk, Arie, Bogers, Ad J.J.C. +2 more·2015·European Journal of Cardio-Thoracic Surgery

Abstract

OBJECTIVES: The surgical approach to repair of tetralogy of Fallot (ToF) has shifted over the years. We aimed to report the long-term follow-up after ToF repair with the transatrial-transpulmonary approach and to determine predictors of long-term outcomes. METHODS: Retrospective analysis of patients operated on in two tertiary referral centres. Primary outcome measures were: death, pulmonary valve replacement (PVR), reintervention for other reasons, internal cardiodefibrillator and/or pacemaker placement. Kaplan-Meier assessment of overall and event-free survival as well as uni- and multivariate analyses of risk factors for outcomes were performed. RESULTS: Four hundred and fifty-three patients were included. Median age at operation was: 0.6 years (range 0-19.6) and median age at the last follow-up was 14.3 years (range 0.1-42.1). Median age at repair decreased from 1.2 years (range 0.6-5.8) (1970-80) to 0.3 years (range 0-4.7) (2000-12). A transannular patch (TP) was used in 65% of all patients. The use of a TP showed a decline from 89% in the initial years of the cohort to 64% in 2000-12. Early mortality was 1.1% (5 patients) for the entire cohort and late mortality 2.4% (11 patients). Overall survival for the entire cohort was 97.3% (95% CI 95.7-98.8) and 91.8% (95% CI 85.9-97.7) at 10 and 25 years, respectively. For patients with a TP (n = 294) vs non-TP (n = 159), this was 97.2% (95% CI 95.2-99.2) vs 97.5% (95% CI 95.1-99.9) at 10-year and 91.0% (95% CI 83.9-98.1) vs 96.3% (95% CI 93.0-99.6) at 25-year follow-up (P = 0.958). Fifty-two patients underwent PVR, and in 5 a pacemaker was inserted. Event-free survival for TP versus non-TP patients was 80.2% (95 CI% 75.5-84.9) vs 81.7% (95% CI 75.2-88.2) at 10-year and 27.9% (95% CI 17.7-38.1) vs 78.5% (95% CI 71.4-85.6) at 25-year follow-up (P = 0.016). In multivariate analysis, both the use of a TP (HR 1.705, 95% CI 1.023-2.842) and the year of surgical repair of tetralogy of Fallot (HR 1.039, 95% CI 1.006-1.073) were associated with a higher probability of an event. CONCLUSIONS: ToF patients corrected with the transatrial-transpulmonary approach have good long-term survival. PVR is a frequent event at longer follow-up, and other events are limited. The use of a TP is a predictor for poorer event-free outcomes, increasing the risk of the composite endpoint 1.7 times.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ejcts/ezu182

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Right ventricle dilatation usually prompts the replacement of the native pulmonary valve at some time during follow-up, with the burden of redo operations every 10 to 15 years thereafter.

    “Right ventricle dilatation therefore usually prompts the replacement of the native pulmonary valve at some time during follow-up, with the burden of redo operations every 10 to 15 years thereafter.12,13”

    From Comparison of Long-term Outcomes of Valve-Sparing and Transannular Patch Procedures for Correction of Tetralogy of Fallot (2021) · cites this paper as [13]

    The Discussion (page unavailable) links right-ventricular dilatation to considerations for pulmonary valve replacement and says many late reinterventions are replacements. But the Long-term outcomes section (page unavailable) reports a first replacement in only 11.5% of patients, at a median of 20.2 years after repair. It does not establish that replacement is usual or that redo operations recur every 10–15 years thereafter. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Prior studies detected no significant difference in long-term survival between patients treated with transannular patch (TAP) vs those with valve-sparing operation despite less valve replacements in the valve-sparing group.

    “In regards to the use of valve vs nonvalve-sparing approach, prior studies detected no significant difference in long-term survival between patients treated with transannular patch (TAP) vs those with valve-sparing operation despite less valve replacements in the valve-sparing group.23,24”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Luijten, L. W. G., van den Bosch, E., Duppen, N., Tanke, R., Roos-Hesselink, J., Nijveld, A., van Dijk, A., Bogers, A. J. J. C., van Domburg, R., & Helbing, W. A.
Affiliations
  • Erasmus MC (NL)
  • Radboud University Medical Center (NL)
Corresponding author
Helbing, Willem A.
Venue
European Journal of Cardio-Thoracic Surgery
Published
2014-05-06
Volume
47
Issue
3
Pages
527-534
ISSN
  • 1010-7940 (ISSN-L)
  • 1873-734X
OpenAlex
W2119242642
Cited by
72
References
25
Citations by year
2026: 2 · 2025: 6 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 10 · 2020: 5 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 5 · 2015: 2 · 2014: 3
FWCI
4.03
Type
journal article
Language
en
Open access
Locations
  • European Journal of Cardio-Thoracic Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Congenital Heart Disease Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiovascular Conditions and Treatments
Keywords
tetralogy of Fallot, transannular patch, long-term outcomes, overall survival, pulmonary valve replacement, reintervention, pacemaker implantation, risk factors, congenital heart surgery, age at repair, pulmonary regurgitation, pulmonary valve stenosis, pulmonary valve insufficiency
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Female, Follow-Up Studies, Cardiac Surgical Procedures, Humans, Infant, Infant, Newborn, Male, Middle Aged, Pulmonary Valve, Retrospective Studies, Tetralogy of Fallot, Treatment Outcome, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review